The radiopharmaceutical, meta-iodobenzylguanidine (MIBG) has been shown to be sensitive and specific for the scintigraphic detection of tumours of neural crest origin, in particular, neuroblastoma (McEwan et al., 1985; Kimmig et al., 1984; Hofnagel et al., 1985; Troncone et al., 1990) . Furthermore, the high degree of specific accumulation of MIBG in this tumour has led to its use in therapy. Recent reports (Lashford et al., 1992) The amine transporter system responsible for accumulation of MIBG in the SK-N-BE(2C) neuroblastoma cell line has less stringent substrate requirements than the transporters on other neural cell types (Lashford et al., 1992) . In addition, it is well established that embryonic neural cells are capable of differentiating into a variety of neuronal phenotypes (Fraser and Bonner-Fraser 1991; Kentroti et al., 1994) . Thus, undifferentiated neuroblastomas may possess embryonic amine transporters with high capacity but reduced selectivity (i.e. the transporter is not yet committed to a particular neurotransmitter). Hence, a variety of compounds may be recognised and transported by the amine uptake system expressed by neuroblastomas. Owing to their ability to interact with a number of neuronal receptor systems, the phenylpiperazines represent a potentially interesting class of compounds for targeting neuroblastoma (Pawowski, 1983; Abuzar and Sharma 1984; Fuller, 1986; Glennon et al., 1991; Lloyd et al., 1985; Lyon et al., 1986; Oepen et al., 1988) . 4-(3-chlorophenyl)-piperazine has been shown to be a serotonin agonist and several other phenylpiperazine derivatives exhibit serotonin receptor activity (Bagdy et al., 1989; Maj and Lewandowska, 1980) . The chlorine-containing phenylpiperazine, 4-(3-chlorophenyl)-piperazine (mCPP) and the fluorinated derivative, 4-(3-trifluoromethylphenyl)-piperazine (mTFMPP), both elicit a dose-dependent release of serotonin from brain slices. This effect is caused by displacement of serotonin stores and not depolarisation (Pettibone and Williams, 1984) . Since this mechanism is similar to that described for the adrenergic neuronal blocking agent, upon which MIBG was based, the phenylpiperazine structure may offer a new basis for developing neuroblastoma imaging agents. The observation that mCPP inhibits serotonin and noradrenaline uptake in rat synaptosomes to a similar degree (1.3 gM vs 5.8 guM respectively) (Samanin et al., 1979) establishes that this ligand interacts with the noradrenaline transporter.
Radioiodinated derivatives of phenylpiperazines have been studied by several investigators. Hanson et al. (1985) have described the biodistribution of several radioiodinated phenylepiperazines including derivatives of 4-phenylpiperazine, the ganglionic-stimulating drug, 1,1-dimethyl-4-phenylpiperazinium (DMPP) (Hanson, 1982; Hanson et al., 1983 ), 1-carboxamidino-4-(['251]iodophenyl)piperazine (Hanson et al., 1986 ) and 1-["C]methyl-4-aryl-piperazinium salts (Elmaleh et al., 1993) . These studies and others (Chumpradit et al., 1989; Hanson and Hasan, 1987) have demonstrated that phenylpiperazine derivatives accumulate in a variety of tissues (brain, adrenal medulla and myocardium) to varying degrees.
These findings led to our investigation of the ability of these ligands to compete for MIBG uptake in cultured neuroblastoma. Initial results indicating that 1-carboxamidino-4-phenylpiperazine (CAPP) inhibits MIBG uptake by SK-N-BE(2C) cells prompted further investigations of this class of compounds as second generation or alternative radiopharmaceuticals for targeting neuroblastoma.
The aims of this study were: (1) to evaluate the ability of selected phenylpiperazine derivatives to compete with MIBG uptake by cultured neuroblastoma cells; (2) Materials and methods Materials All reagents were obtained as the highest available grade from commercial sources. 4-(3-chlorophenyl)-piperazine (mCPP), 4-phenylpiperazine (PP), 4-(3-trifluoro methyl phenyl)-piperazine (TFMPP) (1,1-dimethyl-4-phenyl)-piperazinium hydrochloride (DMPP) and the piperidine derivative chlorophenyl hydroxypiperidine (CP(OH)P), desmethylimipramine (DMI) and serotonin (5HT) were obtained from Sigma Chemical Co. 1-Carboxamidino-4-phenylpiperazine (CAPP) was prepared according to previously described methods (Hanson, 1982) . Structures of the ligands used in this study are shown in Figure 1 .
Synthesis of 1-carboxamidino-4-phenyl-piperazine (CAPP) 4-Phenyl-piperazine hydrochloride (2.00 g), triethylamine (2.50 g) and methylthiopseudourea sulphate (1.50 g) were added to a round bottom flask and the solution was refluxed at 100°C for 6 h using an oil bath. The reaction mixture was then cooled to room temperature and transferred to an ice bath. On cooling the product crystallised. The precipitate was filtered, washed twice with ice-cold water, transferred to a clean preweighed round bottom flask and dried under vacuum overnight. The yield of dry product was 0.54 g. The product was dissolved in 30 ml of 2N HCl and excess HCl was removed by rotary evaporation. The resulting salt was dried under vacuum overnight. The yield of final product was 0.42 g (-17%). (1982) . Radiochemical purity was determined before experimental use. Only preparations with purities of greater than 95% were used. Typically, the specific activity of the radiopharmaceutical was approximately 5 mCi mg-'.
Radioiodination of 4-(3-chloro-phenyl)-piperazine (mCPP) [1251] labelled 4-(3-iodo-phenyl)-piperazine(IPP) was prepared using the solid phase halogen exchange reaction described by Manger et al. (1982) and later applied to iodo-for chlorosubstitution (Gildersleeve, et al., 1989) . One milligram of mCPP in 0.3 ml of water was added to a sterile glass vial followed by 0.3 ml of a 0. Figure 2 shows the effect of increasing concentrations of phenylpiperazine ligands on the uptake of MIBG into SK-N-BE(2C) cells. The concentrations of each ligand required to produce a 50% inhibition of MIBG uptake are summarised in Table I . IPP, CAPP and mCPP had similar IC50 values, within an order of magnitude of MIBG itself. DMPP was slightly less potent than CAPP and mCPP. CP(OH)P and TFMPP had potencies which were approximately 100-and 200-fold lower than the other phenylpiperazines studied. Hence, the order of potency for inhibition of MIBG uptake was PP > CPP = CAPP > DMPP > CP(OH)P > TFMPP (P<0.05).
In an initial radiolabelled tracer for the study of this class of compounds and reflects the previous finding that TFMPP has a significantly lower ability to inhibit MIBG uptake compared with mCPP or IPP. The IC5ss for IPP, CPP and TFMPP were 2.5, 7.0 and >20 giM for SK-N-BE(2C) and 1.8, 9.0 and 40 gM for SK-N-SH respectively. The IC50s for MIBG were 18 and 25,M for SK-N-BE(2C) and SK-N-SH respectively. (Figure 4 ). (Hoyer et al., 1988; Watling, 1988) . but not serotonin uptake transporters (Pranzatelli and Balletti. 1992 
